Literature DB >> 9881702

The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts.

M F Denissenko1, T B Koudriakova, L Smith, T R O'Connor, A D Riggs, G P Pfeifer.   

Abstract

Sequence-dependent formation and lack of repair of polycyclic aromatic hydrocarbon-induced DNA adducts correlates well with the positions of p53 mutational hotspots in smoking-related lung cancers (Denissenko et al, 1996, 1998). The mycotoxin aflatoxin B1 (AFB1) is considered to be a major causative agent in hepatocellular carcinoma (HCC) in regions with presumed high food contamination by AFB1. A unique mutational hotspot, a G to T transversion at the third base of codon 249 of the p53 gene is observed in these tumors. To test whether a selectivity of AFB1 adduct formation is related to this peculiar mutational spectrum, we have mapped AFB1-DNA adducts at nucleotide resolution using ligation-mediated PCR and terminal transferase-dependent PCR. Human HepG2 cells were exposed to AFB1 metabolically activated in the presence of rat liver microsomes. Significant adduct formation was seen at the third base of codon 249. However, this was not the major site of AFB1 adducts and strong adduction was also observed at codons 226, 243, 244, 245 and 248 in exon 7 of the p53 gene and at several codons in exon 8. The damage at codon 249 does not consist of a unique abasic site or ring-opened aflatoxin B1 adduct but rather is consistent with the principal N7-guanine adduct of AFB1. Time course experiments indicate that, under the conditions used, AFB1 adducts are not removed in a strand-selective manner and adduct removal from the third base of codon 249 proceeds at a relatively fast rate (50% in 7 h). The incomplete correspondence between sites of persistent AFB1 damage and the specific codon 249 mutation suggests that AFB1 may not be involved in mutation of this site or that additional mechanisms such as parallel infection with hepatitis B virus may be required for selection of codon 249 mutants in HCC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9881702     DOI: 10.1038/sj.onc.1202214

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  In vivo, high-resolution analysis of yeast and mammalian RNA-protein interactions, RNA structure, RNA splicing and ribozyme cleavage by use of terminal transferase-dependent PCR.

Authors:  H H Chen; D Castanotto; J M LeBon; J J Rossi; A D Riggs
Journal:  Nucleic Acids Res       Date:  2000-04-01       Impact factor: 16.971

Review 2.  An evolutionary paradigm for carcinogenesis?

Authors:  P Vineis; G Matullo; M Manuguerra
Journal:  J Epidemiol Community Health       Date:  2003-02       Impact factor: 3.710

Review 3.  DNA adducts: Formation, biological effects, and new biospecimens for mass spectrometric measurements in humans.

Authors:  Byeong Hwa Yun; Jingshu Guo; Medjda Bellamri; Robert J Turesky
Journal:  Mass Spectrom Rev       Date:  2018-06-11       Impact factor: 10.946

4.  Association of Aflatoxin and Gallbladder Cancer.

Authors:  Jill Koshiol; Yu-Tang Gao; Michael Dean; Patricia Egner; Chirag Nepal; Kristine Jones; Bingsheng Wang; Asif Rashid; Wen Luo; Alison L Van Dyke; Catterina Ferreccio; Michael Malasky; Ming-Chang Shen; Bin Zhu; Jesper B Andersen; Allan Hildesheim; Ann W Hsing; John Groopman
Journal:  Gastroenterology       Date:  2017-04-17       Impact factor: 22.682

5.  A locked nucleic acid clamp-mediated PCR assay for detection of a p53 codon 249 hotspot mutation in urine.

Authors:  Selena Y Lin; Veerpal Dhillon; Surbhi Jain; Ting-Tsung Chang; Chi-Tan Hu; Yih-Jyh Lin; Shun-Hua Chen; Kung-Chao Chang; Wei Song; Lixin Yu; Timothy M Block; Ying-Hsiu Su
Journal:  J Mol Diagn       Date:  2011-07-02       Impact factor: 5.568

Review 6.  Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review.

Authors:  Gerald N Wogan; Thomas W Kensler; John D Groopman
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2011-06-01

Review 7.  Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair.

Authors:  Helmut Bartsch; Jagadeesan Nair
Journal:  Langenbecks Arch Surg       Date:  2006-08-15       Impact factor: 3.445

Review 8.  Somatic TP53 Mutations in the Era of Genome Sequencing.

Authors:  Pierre Hainaut; Gerd P Pfeifer
Journal:  Cold Spring Harb Perspect Med       Date:  2016-11-01       Impact factor: 6.915

9.  Potential role of p53 mutation in chemical hepatocarcinogenesis of rats.

Authors:  Wei-Guo Deng; Yan Fu; Yu-Lin Li; Toshihiro Sugiyama
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

10.  In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure.

Authors:  Ahmad Besaratinia; Sang-In Kim; Pierre Hainaut; Gerd P Pfeifer
Journal:  Gastroenterology       Date:  2009-06-12       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.